Bedside heart monitoring for acute heart failure
This trial tests whether checking a blood marker called NT-proBNP at your bedside while in the hospital helps doctors better manage acute heart failure. It could lead to more personalized treatment and a clearer picture of your recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are in the hospital's cardiac intensive care unit (a special heart unit) with acute heart failure that has suddenly gotten worse.
- You have signs of fluid build-up, such as shortness of breath, swelling in legs, or fluid in the lungs.
- You are receiving standard heart failure treatment, including water pills (diuretics) through an IV.
- You or someone legally allowed to decide for you can agree to take part.
- You do not have severe shock, need a dialysis machine, or have a life expectancy shorter than 72 hours.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a simple blood test (NT-proBNP) to find heart failure early in people who have symptoms but haven't been diagnosed yet. If the test levels are high, it could help doctors start treatment sooner.
This trial tests whether simple screening using a blood test (natriuretic peptides) plus an ultrasound of the heart (echocardiogram) can find early heart failure sooner. Finding it earlier may help doctors start the right management to prevent it from getting worse.
This study is a registry that collects information about people who come to care with sudden (acute) worsening heart failure symptoms. If your test shows a higher BNP level, your doctors may use your details to better understand and track acute heart failure care.
This trial tests a new blood test (NTproBNP) to help diagnose heart failure. It is looking for existing blood samples from people with current or past heart failure symptoms or diagnosis.
This study tests a new diagnostic toolkit that uses blood markers to help doctors personalize heart failure treatment. The goal is to better manage your symptoms and reduce hospitalizations.
This trial checks whether using a blood test (a “biomarker”) can help doctors decide when it’s safe to send people home after a hospital stay for worsening heart failure. It may help reduce avoidable readmissions while keeping you safe.
Hear when a new Acute Decompensated Heart Failure (ADHF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.